Close
Close
Stefan Weber, Newron Pharmaceuticals: Company Overview and Focus on Rett Syndrome
221 views
2.66666666667
2.7 from 6 votes

Stefan Weber, CEO of Newron Pharmaceuticals provides a company overview and the focus on Rett Syndrome. Newron is focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system.

Xadago (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland and the USA, and is commercialized by Newron’s Partner Zambon. Newron also has a strong pipeline of promising treatments for rare disease patients at various stages of clinical development, including sarizotan for patients with Rett syndrome. This discussion focuses on Rett syndrome.

by Abidemi Uruejoma
5 views 2 days ago
by Abidemi Uruejoma
56 views 2 weeks ago
by Abidemi Uruejoma
42 views 3 weeks ago
by Abidemi Uruejoma
56 views 1 month ago
by Abidemi Uruejoma
99 views 1 month ago
by Abidemi Uruejoma
101 views 1 month ago
by Abidemi Uruejoma
113 views 2 months ago
by Abidemi Uruejoma
132 views 2 months ago
2.66666666667
2.7 from 6 votes
Free Newsletter
Find a Clinical Trial
Related Videos
by Abidemi Uruejoma
344 views
by Abidemi Uruejoma
349 views
by Abidemi Uruejoma
607 views